Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone/metformin fixed-dose combination versus uptitrated metformin in type 2 diabetes inadequately controlled on metformin
ChiCTR1900028606Phase 4Not yet recruiting
- Sponsor
- Beijing Hospital
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of pioglitazone and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Beijing Hospital. Primary endpoint: Glycated hemoglobin. Planned start Dec 2019; status: not yet recruiting.
02
Drugs
pioglitazonemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1900028606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028606.